SMMT   $18.99  3.09% Market Closed After Close 18.96 -0.16%

Summit Therapeutics Inc

EMA (20): 2024-11-13 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-11-20 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

EMA (100): 2024-05-30 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.

Trend Type flat and up
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -2.41%
EMA (20) date of signal Nov. 13, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield 2.04%
EMA (50) date of signal Nov. 20, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 74.15%
EMA (100) date of signal May 30, 2024, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 22, 2024, 3 a.m.
MACD Signals bearish
MACD Yield 2.04%
MACD date of signal Nov. 20, 2024, 3 a.m.
Stochastic Signals bearish recovery
Stochastic Yield 0.0
Stochastic date of signal Nov. 22, 2024, 3 a.m.
Updated Nov. 24, 2024, 11:04 p.m.